Connect with us

Health

These 5 balding and hair loss treatments could help ensure a healthy scalp, experts say

Published

on

These 5 balding and hair loss treatments could help ensure a healthy scalp, experts say

Join Fox News for access to this content

Plus special access to select articles and other premium content with your account – free of charge.

By entering your email and pushing continue, you are agreeing to Fox News’ Terms of Use and Privacy Policy, which includes our Notice of Financial Incentive.

Please enter a valid email address.

Having trouble? Click here.

Hair loss can be a frustrating byproduct of aging.

About 70% of men will lose hair as they age, while half will experience hair loss by age 50, according to Cleveland Clinic.

Advertisement

Approximately 80% of cases of male pattern baldness are due to genetic factors, studies have shown.

Among women, up to 40% will have noticeable hair loss by age 50, UCLA Health reported.

CURE FOR MEN’S HAIR LOSS COULD BE FOUND IN SUGAR STORED IN THE BODY, STUDY SUGGESTS

Hair loss can be a factor in mental health struggles, research has shown. 

A 2022 study found that adults with alopecia areata (an autoimmune disease that causes hair loss) were up to 38% more likely to experience clinical depression, according to the National Alopecia Areata Foundation.

Advertisement

Jimmy Sung, MD, told Fox News Digital “finding a specialist who focuses on evidence-based hair restoration and regeneration is essential.” (iStock)

For those looking to minimize and prevent balding, the following five treatments could be helpful, experts say.

1. Minoxidil

Manhattan-based dermatologist Dr. Brendan Camp, MD, recommends starting with the over-the-counter topical minoxidil, which does not require a prescription.

“It is thought to help keep hair in the growing phase, also known as anagen,” he told Fox News Digital.

HAIR LOSS AND PROSTATE MEDICATION COULD ALSO REDUCE HEART DISEASE RISK, STUDY FINDS

Advertisement

It is important to prevent the topical form of minoxidil from dripping onto the face, Camp warned, as it can promote hair growth in unwanted areas.

Oral minoxidil was also recommended as an off-label treatment for hair loss. This version of the medication does require a prescription.

“In men with male pattern hair loss, it is important to use a DHT blocker combined with something like minoxidil to improve blood flow to the scalp,” a doctor said. (iStock)

The medicine is normally prescribed to treat high blood pressure, according to Camp, but one of its side effects is hair growth.

HAIR LOSS AND PROSTATE MEDICATION COULD ALSO REDUCE HEART DISEASE RISK, STUDY FINDS

Advertisement

“Minoxidil is prescribed at low doses to treat hair loss to take advantage of this side effect and promote hair growth,” Camp said.

2. Oral finasteride

Oral finasteride is an FDA-approved treatment for male androgenetic alopecia, which is also known as male pattern baldness, Camp said.

Finasteride works by limiting the formation of a hormone called DHT, which is responsible for hair shrinkage and hair loss, the doctor said.

Minoxidil and finasteride are both effective and have an “established track record in treating hair loss,” a doctor said. (iStock)

Las Vegas dermatologist Dr. Candace Spann, MD, the creator of ReTress, a hair care formula for women experiencing hair loss, echoed the importance of targeting DHT with a blocker to “improve blood flow to the scalp” and boost hair growth in men.

Advertisement

Jimmy C. Sung, MD, board-certified plastic and reconstructive surgeon and medical director of Tribeca Aesthetics in New York City, agreed with Spann and Camp that minoxidil and finasteride are both effective and have an “established track record in treating hair loss.”

3. Platelet-rich plasma (PRP)

Platelet-rich plasma (PRP) is a treatment administered in a medical provider’s office, where a patient’s blood is drawn and spun to separate the plasma from the red blood cells, according to Camp.

MAXIMIZE HAIR GROWTH WITH THESE OILS THAT CAN EASILY BE ADDED TO YOUR DAILY SELF-CARE ROUTINE

The plasma, which is rich in platelets and “growth factors,” is then injected into the scalp to “improve hair density and caliber,” he said.

PRP has also been used for wound healing in trauma and joint injuries, according to Johns Hopkins Medicine, but has been gaining popularity in addressing male pattern baldness and stimulating the growth of hair transplants.

Advertisement

PRP is a treatment administered in-office, where a patient’s blood is drawn and spun to separate the plasma from the red blood cells. (Paul Chinn/The San Francisco Chronicle via Getty Images)

Results are most noticeable six months after the scalp injections. The procedure is not permanent, and additional injections may be needed, experts say.

Sung called hair transplants an “excellent solution for hair restoration for patients who are good candidates and looking for long-term solutions.”

NEW PROSTATE CANCER MEDICATION ‘SHOWS PROMISE’ IN TREATING AGGRESSIVE DISEASE, STUDY FINDS

“Platelet-rich plasma injections enhance hair transplant results and benefit some non-transplant patients,” he told Fox News Digital.

Advertisement

4. Saw palmetto 

An alternative treatment for hair loss, saw palmetto is a plant-based, over-the-counter supplement.

“Saw palmetto is thought to reduce the amount of DHT hormone that contributes to hair loss,” Camp said.

Saw palmetto, a palm native to the southeastern U.S., is commonly used in supplements to “improve prostate health, balance hormone levels and prevent hair loss in men,” according to Healthline. (DeAgostini/Getty Images)

“The evidence behind the use of saw palmetto as an effective treatment for hair loss is limited, and OTC supplements are not FDA-regulated,” he noted.

A 2020 study published by the National Institutes of Health noted a 60% improvement in overall hair quality among patients experiencing hair loss who used various oral and topical saw palmetto products.

Advertisement

CLICK HERE TO SIGN UP FOR OUR HEALTH NEWSLETTER

The study also found that 27% of participants saw improved total hair count, 83% reported increased hair density and 52% said the hair loss stopped progressing.

5. Scalp treatments and vitamin therapy

Treating hair loss in both men and women is a “multifaceted approach,” Spann said, involving the treatment of other issues like low vitamin D or scalp inflammation.

For more Health articles, visit www.foxnews/health

“Treating female pattern hair loss is more complicated, because it requires addressing all underlying causes,” she told Fox News Digital.

Advertisement

Treating women’s hair loss is “more complicated,” a dermatologist said. (iStock)

“It is crucial to improve blood flow to the scalp, calm scalp inflammation and correct underlying vitamin deficiencies.”

Those experiencing scalp inflammation, or scalp folliculitis, should see a board-certified dermatologist to identify the cause of the condition and determine the proper treatment.

Some cases of scalp inflammation can be remedied at home with a warm compress, antibiotic ointment, antihistamines, or an antifungal or anti-dandruff shampoo. (iStock)

Some cases can be remedied at home with a warm compress, antibiotic ointment, antihistamines, or an antifungal or anti-dandruff shampoo, according to the Valley Skin Institute website.

Advertisement

In some cases, however, the condition may require prescription-strength medication.

A 2020 study published by the National Institutes of Health noted a 60% improvement in overall hair quality among patients experiencing hair loss who used various oral and topical saw palmetto products. (iStock)

“It is also important to correct iron deficiencies, low iron stores and low vitamin D levels,” Spann added.

Many vitamins and minerals play a role in healthy hair growth, according to Harvard Health.

Some of these include vitamins A, B2 (riboflavin), B3 (niacin), B7 (biotin), B9 (folate), B12, C, D and E, as well as iron, selenium and zinc.

Advertisement

“Consuming adequate vitamins and minerals is important to preventing and managing hair loss,” states the Harvard Health website. “Most people can cover all their nutritional needs through a healthy, balanced diet.”

Those who have questions about choosing the right hair loss treatment should consult a medical provider, experts recommend.

Health

New cancer vaccine delivers stunning result against one of the deadliest skin cancers

Published

on

New cancer vaccine delivers stunning result against one of the deadliest skin cancers

NEWYou can now listen to Fox News articles!

A new injectable therapy is showing positive results in reducing melanoma throughout a five-year period.

The personalized mRNA cancer therapy, called intismeran autogene, combined with the cancer immunotherapy drug KEYTRUDA (pembrolizumab), is a collaboration between Merck and Moderna.

The results from the phase 2b KEYNOTE-942 study were presented at the American Society of Clinical Oncology (ASCO) Annual Meeting in Chicago on May 27.

CLICK HERE FOR MORE HEALTH STORIES

Advertisement

After about a five-year follow-up, the combo drug was found to reduce the risk of melanoma recurrence or death by 49% compared to pembrolizumab alone.

The researchers analyzed data from 157 patients with high-risk stage 3 and 4 melanoma whose cancer had been removed via surgery. The participants were split into two groups — one received the combo therapy and the other only received pembrolizumab, according to a press release.

The therapy was found to reduce the risk of melanoma recurrence or death by 49% compared to pembrolizumab alone after a five-year follow-up. (iStock)

The findings revealed that the combination group saw benefits that were “sustained and durable over time.”

Intismeran autogene is designed using mutations identified in a patient’s own tumor, with the intention of teaching the immune system what the cancer looks like so that it can recognize and attack it.

Advertisement

CLICK HERE TO SIGN UP FOR OUR HEALTH NEWSLETTER

According to the researchers, intismeran is “well-tolerated” with a “manageable” safety profile. 

The most commonly cited side effects of the personalized mRNA vaccine plus KEYTRUDA were fatigue, injection-site pain, chills, fever and headache. The researchers reported no new long-term safety concerns and no severe vaccine-related adverse events.

The combination therapy is currently being evaluated in a phase 3 study — the final confirmation stage.

Patients with late-stage melanoma have a “significant risk” of cancer recurrence, according to an expert. (iStock)

Advertisement

In a Merck press release from January, Kyle Holen, MD, Moderna’s senior vice president and head of development, oncology and therapeutics, noted that this data highlights the “potential of a prolonged benefit … in patients with resected high-risk melanoma.”

CLICK HERE TO DOWNLOAD THE FOX NEWS APP

“We continue to invest in our platform in oncology because of encouraging outcomes like these, which illustrate mRNA’s potential in cancer care,” he said.  

Dr. Marjorie Green, senior vice president and head of oncology, global clinical development at Merck Research Laboratories, also commented that for many patients with stage 3 or 4 melanoma, there is a “significant risk of recurrence following surgery.”

Researchers confirmed that the combination therapy is currently being evaluated in a phase 3 study. (iStock)

Advertisement

“As such, demonstrating the longer-term potential of intismeran autogene and KEYTRUDA to reduce the risk of recurrence for certain patients with melanoma is a meaningful milestone,” she said.

TEST YOURSELF WITH OUR LATEST LIFESTYLE QUIZ

The company cited encouraging five-year follow-up data and pointed to upcoming late-stage INTerpath trial results with Moderna in several hard-to-treat cancers.

Continue Reading

Health

New ways to prevent flu revealed in ‘accidental’ lab breakthrough, study finds

Published

on

New ways to prevent flu revealed in ‘accidental’ lab breakthrough, study finds

NEWYou can now listen to Fox News articles!

An accidental lab discovery has opened the door to entirely new ways of preventing the flu.

While investigating how influenza replicates, researchers discovered that different flu strains use completely different strategies to infiltrate human cells, SWNS reported.

By targeting the specific molecules the viruses rely on, scientists found that they could block them from entering new cells and halt their replication altogether.

5 THINGS YOU NEED TO KNOW BEFORE GETTING YOUR FLU SHOT, ACCORDING TO DOCTORS

Advertisement

Researchers say these “fundamental insights” into seasonal influenza highlight a clear path toward developing better preventive medications.

“The hope is that fundamental, curiosity-based research like this helps to pave the way for novel strategies to treat and prevent influenza infections,” principal investigator Dr. Emily Bruce, from the University of Vermont’s Larner College of Medicine, said in the SWNS report.

While investigating how influenza replicates, researchers discovered that different flu strains use completely different strategies to infiltrate human cells. (iStock)

While several flu strains cause illness, H1N1 and H3N2 influenza A viruses are the most common. However, current flu tests cannot differentiate between them, and clinical treatments are identical for both.

Although vaccines and antivirals are available, Bruce noted a “dire” need for better medications to stop the virus from spreading cell to xxcell.

Advertisement

“You don’t get sick when a virus is in one cell,” he noted. “You get sick because a virus replicates itself and goes into many more cells.”

HOW LONG YOU’RE CONTAGIOUS WITH THE FLU — AND WHEN IT’S SAFE TO GO OUT

The study, which was published in The Journal of Virology, originally aimed to map how viral RNA segments are transported within cells to create new viral particles.

The team used H1N1 and H3N2 viruses isolated from the nasal passages of positive patients in 2022.

Clinical treatments remain identical for both primary strains of the flu virus. (iStock)

Advertisement

During the investigation, the team unexpectedly stumbled upon a cellular pathway that blocked the virus from entering lung cells, SWNS reported.

RESEARCHERS LOCKED FLU PATIENTS IN A HOTEL WITH HEALTHY ADULTS — NO ONE GOT SICK

The data revealed that when a specific human protein called Rab11B was depleted, H3N2 viruses failed to enter human lung cells. H1N1 viruses were completely unaffected.

Using reverse genetics, the team mapped this defect and uncovered a brand-new, H3N2-specific role for Rab11B during viral entry.

CLICK HERE FOR MORE HEALTH STORIES

Advertisement

This discovery challenged the scientific assumption that all flu viruses enter cells the same way.

CLICK HERE TO SIGN UP FOR OUR HEALTH NEWSLETTER

“Viruses are like pirates from different countries hijacking someone’s ship,” Bruce said. “Different viruses, like different types of pirates, use different methods to get onboard.”

This discovery challenged the scientific assumption that all flu viruses enter cells the same way. (iStock)

“We had previously thought that all flu viruses used the same way to get into a cell, but we discovered that this is not true,” she went on. “H1N1 and H3N2 need different proteins to get in, and if you get rid of the right protein, a specific virus can’t get in.”

Advertisement

CLICK HERE TO DOWNLOAD THE FOX NEWS APP

While these findings identify a critical cellular pathway for viral entry, the study was conducted using isolated cells, the researchers acknowledged.

TEST YOURSELF WITH OUR LATEST LIFESTYLE QUIZ

Further research is needed to determine whether blocking the protein is safe and effective within a live, complex human respiratory system.

Bruce and the team hope to conduct further research to determine whether this Rab11B-dependency is a fundamental property of H3N2, or if it’s a trait unique to currently circulating flu strains.

Advertisement

Continue Reading

Health

One extra serving of processed meat a day linked to higher cancer risk

Published

on

One extra serving of processed meat a day linked to higher cancer risk

NEWYou can now listen to Fox News articles!

Eating processed meat like ham, sausage and bacon may be linked to a higher risk of certain types of cancer, according to new research.

While health organizations have already confirmed that processed meat can contribute to colon cancer, this study looked closer at cancers in the upper digestive tract, where the link has historically been less clear.

To understand these connections, researchers from the European Prospective Investigation into Cancer and Nutrition (EPIC), one of the world’s largest long-term nutrition and cancer cohorts, tracked the health and diets of 450,112 people across Europe for an average of 14 years. 

FREQUENT HEARTBURN MAY BE A WARNING SIGN OF A MORE DANGEROUS CONDITION, DOCTOR SAYS

Advertisement

The study group included 131,426 men and 318,686 women, according to the study’s press release.

During the follow-up period, 876 people developed stomach cancer and 215 people developed esophageal adenocarcinoma, which is cancer of the tube connecting the mouth to the stomach.

For female participants, eating both processed meat and white meat was linked to an increased risk of developing the disease. (iStock)

Researchers tracked where the stomach cancers grew, separating them into the upper part of the stomach near the throat and the lower part of the stomach.

The researchers also sorted the tumors into two categories based on how the cancer cells appeared under a microscope: intestinal, which forms more organized structures, and diffuse, in which the cells are more scattered throughout the tissue.

Advertisement

BACTERIA IN YOUR MOUTH MAY TRAVEL TO THE GUT AND TRIGGER STOMACH CANCER, RESEARCH FINDS

After adjusting for other lifestyle factors, the researchers found that for every extra 30 grams of processed meat a person ate per day, their overall risk of stomach cancer went up by 9%. Eating that same extra 30 grams a day was also linked to a 13% higher risk of esophageal adenocarcinoma.

A standard single slice of regular deli-sliced ham or lunch meat averages around 28 grams, according to USDA data and nutritional tracking databases.

An extra 20 grams of white meat, such as chicken and turkey, was linked to a 12% higher risk of cancer in the main body of the stomach. (iStock)

An extra 20 grams of white meat, such as chicken or turkey, was linked to a 12% higher risk of cancer in the main body of the stomach, the researchers noted.

Advertisement

The study also revealed differences between men and women. For male participants, only processed meat showed a clear, statistically significant link to a higher risk of stomach cancer. For female participants, however, eating both processed meat and white meat was linked to an increased risk.

CLICK HERE FOR MORE HEALTH STORIES

These findings align with global health benchmarks, particularly those established by the World Health Organization’s International Agency for Research on Cancer.

The agency has long classified processed meat as a known human carcinogen, primarily due to its strong, well-documented links to colorectal cancer.

CLICK HERE TO SIGN UP FOR OUR HEALTH NEWSLETTER

Advertisement

However, health organizations have also consistently pointed to a potential, yet less definitive, relationship between these meats and cancers of the stomach.

Eating 30 grams of processed meat a day, or the equivalent to one slice of ham, was linked to a 13% higher risk of esophageal adenocarcinoma. (iStock)

Further scientific investigation is needed to confirm the findings and to account for other underlying risk factors, such as certain stomach infections, which could interact with dietary habits.

TEST YOURSELF WITH OUR LATEST LIFESTYLE QUIZ

A key limitation of the study is its reliance on self-reported diets, which can sometimes lead to inaccuracies in how participants recall their meat consumption over time, the researchers noted.

Advertisement

CLICK HERE TO DOWNLOAD THE FOX NEWS APP

The findings were published in the International Journal of Cancer.

Fox News Digital reached out to the researchers requesting comment.

Continue Reading
Advertisement

Trending